Baseline Therapeutics
2 known investors
Baseline is a biotech company focused on metabolism, obesity, incretins, and GLP-1-based strategies for substance use disorders, drawing on drug development and addiction medicine expertise. It develops therapies and brings drug candidates through clinical and regulatory pathways.
Investors · 2
In the news
Frequently asked questions
- What does Baseline Therapeutics do?
- Baseline is a biotech company focused on metabolism, obesity, incretins, and GLP-1-based strategies for substance use disorders, drawing on drug development and addiction medicine expertise. It develops therapies and brings drug candidates through clinical and regulatory pathways.
- Who are Baseline Therapeutics's investors?
- Baseline Therapeutics's investors include Very Serious Ventures, Versant Ventures.